For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Institutional Review Board (IRB)

The Institutional Review Board (IRB) is an administrative body established to protect the rights and welfare of human research subjects recruited to participate in research activities conducted under the auspices of the institution with which it is affiliated. In this section, you will find more detailed information on:

Drexel Institutional Review Board (IRB)

Drexel University has three internal Institutional Review Boards (IRBs) onsite supported by faculty and professional staff members as well as representatives from the local community.

Learn More

Smart Institutional Review Board (IRB)

Streamlined, Multisite, Accelerated Resources for Trials (SMART) IRB Reliance Platform

Learn More

Western Institutional Review Board (WIRB)

Drexel University has an agreement in place authorizing the Western Institutional Review Board (WIRB) to review and approve industry-sponsored, multi-center clinical trials involving adult medical subjects on behalf of our investigators.

Learn More

Schulman Institutional Review Board (IRB)

Drexel University has had an agreement in place authorizing the Schulman Institutional Review Board (Schulman IRB) to review and approve industry-sponsored, multi-center clinical trials involving adult medical subjects on behalf of Drexel investigators.

Learn More

National Cancer Institute Central Institutional Review Board (NCI CIRB)

Drexel University has had an agreement in place authorizing the National Cancer Institute Central Institutional Review Board (NCI CIRB) to review and approve, on behalf of Drexel investigators, Cancer Oncology Group (COG) pediatric clinical trials that are conducted at  St. Christopher's Hospital for Children (SCHC) and adult oncology clinical trials through Drexel University College of Medicine.

Learn More